{
    "2021-11-29": [
        [
            {
                "time": "2022-11-05",
                "original_text": "Merck (MRK) COVID Pill Less Effective in Final Study, Stock Down",
                "features": {
                    "keywords": [
                        "Merck",
                        "COVID",
                        "Pill",
                        "Less Effective",
                        "Final Study",
                        "Stock Down"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-11-05",
                "original_text": "Adagio Therapeutics Upgraded at Morgan Stanley on Omicron Potential",
                "features": {
                    "keywords": [
                        "Adagio Therapeutics",
                        "Upgraded",
                        "Morgan Stanley",
                        "Omicron",
                        "Potential"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}